Lv1
80 积分 2025-03-23 加入
Tirzepatide for Weight Reduction in Chinese Adults With Obesity
2天前
已完结
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
1个月前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
1个月前
已完结
Duchenne型肌营养不良多学科管理指南
2个月前
已完结
Faculty Opinions recommendation of M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy
3个月前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
4个月前
已完结
Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions
4个月前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
4个月前
已完结
[Consensus on clinical application of transient elastography detecting liver fibrosis: a 2018 update]
6个月前
已完结
Chinese consensus on the management of liver cirrhosis
6个月前
已完结
皖公网安备34019202002308
